Illuminare Biotechnologies
PrivateLast Round
Seed Round
May 7, 2026
Total Funding Raised
$2.37M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Illuminare Biotechnologies operates in Healthcare & Life Sciences and is based in Brooklyn, New York. Its latest recorded funding round was a Series A round in August 2017.
Illuminare Biotechnologies is a biotechnology company that develops an intra-operative nerve visualization technology intended to reduce the risk of nerve damage.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Imaging, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Illuminare Biotechnologies Comparables
Compare Illuminare Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Trace Biosciences | 92% | |
| Alume Biosciences | 90% | |
| Dendrite Imaging, Inc. | 75% |
For institutional investors. Book with your work email.
Illuminare Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | May 7, 2026 | ||||
| Series A | Aug 18, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Illuminare Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Thylacine Capital | Convertible Debt, Seed Round |
| Band of Angels | Seed Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 175% MoM.
- May 7, 2026
Raised $3.65M in a seed funding round.
For institutional investors. Book with your work email.
Illuminare Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Illuminare Biotechnologies's valuation, stock price, and market status.
Is Illuminare Biotechnologies a public or private company?
Illuminare Biotechnologies is a private company.
What is the current stock price of Illuminare Biotechnologies?
Illuminare Biotechnologies is a private company, so its shares have no public market price. Caplight tracks Illuminare Biotechnologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Illuminare Biotechnologies worth (valuation)?
Valuation information for Illuminare Biotechnologies is not publicly available.
Can I buy Illuminare Biotechnologies stock?
Illuminare Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Illuminare Biotechnologies's last funding round?
Illuminare Biotechnologies's most recent funding round was Seed Round on May 7, 2026.
Who are the main investors in Illuminare Biotechnologies?
Key investors in Illuminare Biotechnologies include Thylacine Capital, Band of Angels.
Will Illuminare Biotechnologies IPO soon?
No public IPO plans have been announced for Illuminare Biotechnologies.
How can I track Illuminare Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades in Illuminare Biotechnologies's shares on secondary markets.